Condition
Renal Insufficiency,Chronic
Total Trials
5
Recruiting
0
Active
0
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results33% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Terminated2
Unknown1
Completed1
Enrolling By Invitation1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07245186Enrolling By InvitationPrimary
Strategies for Proactive Health in People With Kidney Function Decline
NCT04146012Phase 3TerminatedPrimary
BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial
NCT02957864Phase 4UnknownPrimary
Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide
NCT02964429Not ApplicableCompleted
Determination In-vivo KUF for Diacap Pro Hemodialyser
NCT00338091Not ApplicableTerminatedPrimary
Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
Showing all 5 trials